Kuehne + Nagel International AG
The new contract significantly deepens and extends the business relationship that has already existed between Kuehne + Nagel and Mölnlycke Health Care for many years. In addition to global seafreight activities, Kuehne + Nagel in Singapore will now manage the inbound freight from US, European and Asian factories, and support the regional warehousing and distribution activities to eight countries in the Asia Pacific region. The Mölnlycke Health Care Service Centre located in Singapore will manage the sales orders from the Asian distributors and hand them over to Kuehne + Nagel for order preparation. Key service components in this field include production / lot number control for product traceability and expiry date management.
“This new agreement provides us with a global logistics platform in Asia and enables us to offer shorter lead times to our customers. The partnership with Kuehne + Nagel will enhance the service level for our customers and help us to accelerate growth in the region,“ says Stefan Fransson, Senior Vice President Global Supply, Mölnlycke Health Care.
Decisive factors for Mölnlycke Heath Care to select Kuehne + Nagel for its logistics activities in Asia were the company’s industry-specific competence, its highly advanced information technology which allows for visibility along the entire supply chain, as well as its newly opened logistics facility in Singapore.
“We are very pleased about the extension of our partnership with Mölnlycke Health Care,“ says Dirk Reich, Executive Vice President Contract Logistics, Kuehne + Nagel International AG. “It confirms the value of our integrated service offering and global logistics network as well as our expertise in the healthcare sector.“
About Mölnlycke Health Care
Mölnlycke Health Care, with its corporate headquarters in Gothenburg, Sweden, is one of the world’s leading manufacturers of single-use products for surgical interventions and wound care. The surgical products are marketed under three brands, BARRIER®, Klinidrape® and ProcedurePakTM and the wound care range under the Tendra® brand.
Total annual sales are at present about SEK 4 500 million, and the number of employees is about 4,000. Manufacturing takes place in five factories located in Finland, Belgium, the Czech Republic, Thailand and Mexico. Sales and marketing are carried out in four market areas; Europe/the Middle East/Africa, North America, Latin America and Asia Pacific, altogether comprising 25 subsidiaries and a number of international representative offices.
Further information is available at www.molnlycke.net